Searching... Searching...
  • NVP -2.10%
  • Köp 1.40
  • Sälj 1.41
  • Senast 1.40
  • SEK

  • NEVPF +NA
  • Buy NA
  • Sell NA
  • Latest NA
  • USD

Analysts’ lunch

Analysts' lunch on 22 November 2018, 12 – 1.30 pm CET at Cord Communications in Stockholm.

CEO Erik Kinnman will be presenting the interim report focusing on the development of the clinical projects in NeuroVive's portfolio. NeuroVive's Chief Medical Officer, Magnus Hansson, and Mark Farmery, VP Business Development, will aso take part.